Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(29%)
Results Posted
75%(3 trials)

Phase Distribution

Ph not_applicable
1
14%
Ph early_phase_1
3
43%
Ph phase_2
3
43%

Phase Distribution

3

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
3(42.9%)
Phase 2Efficacy & side effects
3(42.9%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(4)

Detailed Status

Completed4
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 13 (42.9%)
Phase 23 (42.9%)
N/A1 (14.3%)

Trials by Status

completed457%
not_yet_recruiting114%
recruiting229%

Recent Activity

2 active trials
Showing 5 of 7
completedearly_phase_1

The Role of NaV1.8 in Human Pain Models

NCT07511400
not_yet_recruitingearly_phase_1

Pain Induced by m-Cresol as Preservative

NCT07600814
recruitingphase_2

Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells

NCT05705024
recruitingearly_phase_1

Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis

NCT06882811
completednot_applicable

One-month Clinical Evaluation of Oté Sensation Multi-Purpose Solution Care System

NCT03278223
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07511400Early Phase 1

The Role of NaV1.8 in Human Pain Models

Completed
NCT07600814Early Phase 1

Pain Induced by m-Cresol as Preservative

Not Yet Recruiting
NCT05705024Phase 2

Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells

Recruiting
NCT06882811Early Phase 1

Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis

Recruiting
NCT03278223Not Applicable

One-month Clinical Evaluation of Oté Sensation Multi-Purpose Solution Care System

Completed
NCT02362646Phase 2

Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients

Completed
NCT01442129Phase 2

The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7